Larimar Therapeutics Stock Price History
| LRMR Stock | USD 2.51 0.06 2.33% |
If you're considering investing in Larimar Stock, it is important to understand the factors that can impact its price. As of today, the current price of Larimar Therapeutics stands at 2.51, as last reported on the 21st of March, with the highest price reaching 2.60 and the lowest price hitting 2.50 during the day. Larimar Therapeutics has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14 % return per unit of risk over the last 3 months. Larimar Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Larimar Therapeutics' Mean Deviation of 3.55, standard deviation of 4.59, and Risk Adjusted Performance of (0.12) to check out the risk estimate we provide.
Larimar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Larimar |
Sharpe Ratio = -0.1425
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LRMR |
Estimated Market Risk
| 4.59 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.65 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Larimar Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Larimar Therapeutics by adding Larimar Therapeutics to a well-diversified portfolio.
Larimar Therapeutics Stock Price History Chart
There are several ways to analyze Larimar Stock price data. The simplest method is using a basic Larimar candlestick price chart, which shows Larimar Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 3, 2025 | 4.18 |
| Lowest Price | March 18, 2025 | 2.37 |
Larimar Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Larimar Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Larimar Stock. It can be used to describe the percentage change in the price of Larimar Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Larimar Stock.| Larimar Therapeutics Price Action Indicator | (0.07) | |
| Larimar Therapeutics Price Daily Balance Of Power | (0.60) | |
| Larimar Therapeutics Price Rate Of Daily Change | 0.98 |
Larimar Therapeutics March 21, 2025 Stock Price Analysis
Larimar Stock Price History Data
The price series of Larimar Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.81 with a coefficient of variation of 14.23. The daily prices for the period are spread out with arithmetic mean of 3.32. The median price for the last 90 days is 3.34. The company underwent 1:12 stock split on 29th of May 2020. Larimar Therapeutics issued dividends to stockholders on 2020-05-29.| Open | High | Low | Close | Volume | ||
03/21/2025 | 2.52 | 2.60 | 2.50 | 2.51 | ||
| 03/20/2025 | 2.52 | 2.60 | 2.50 | 2.51 | 476,007 | |
| 03/19/2025 | 2.39 | 2.61 | 2.39 | 2.57 | 1,287,093 | |
| 03/18/2025 | 2.55 | 2.55 | 2.29 | 2.37 | 1,634,633 | |
| 03/17/2025 | 2.59 | 2.64 | 2.50 | 2.55 | 1,053,286 | |
| 03/14/2025 | 2.65 | 2.70 | 2.57 | 2.59 | 486,202 | |
| 03/13/2025 | 2.71 | 2.79 | 2.54 | 2.61 | 506,979 | |
| 03/12/2025 | 2.69 | 2.76 | 2.62 | 2.69 | 1,095,855 | |
| 03/11/2025 | 2.92 | 2.95 | 2.60 | 2.65 | 1,265,223 | |
| 03/10/2025 | 2.99 | 3.05 | 2.82 | 2.88 | 291,194 | |
| 03/07/2025 | 3.05 | 3.19 | 3.01 | 3.03 | 285,014 | |
| 03/06/2025 | 3.08 | 3.16 | 3.02 | 3.06 | 349,109 | |
| 03/05/2025 | 2.80 | 3.19 | 2.80 | 3.18 | 565,067 | |
| 03/04/2025 | 2.63 | 2.84 | 2.52 | 2.79 | 647,547 | |
| 03/03/2025 | 3.03 | 3.03 | 2.63 | 2.65 | 440,680 | |
| 02/28/2025 | 2.88 | 3.03 | 2.86 | 3.03 | 365,276 | |
| 02/27/2025 | 2.94 | 3.04 | 2.87 | 2.92 | 412,508 | |
| 02/26/2025 | 2.96 | 3.09 | 2.90 | 2.93 | 503,218 | |
| 02/25/2025 | 3.03 | 3.12 | 2.88 | 2.95 | 740,776 | |
| 02/24/2025 | 3.20 | 3.22 | 3.01 | 3.03 | 535,397 | |
| 02/21/2025 | 3.33 | 3.35 | 3.17 | 3.19 | 514,331 | |
| 02/20/2025 | 3.35 | 3.41 | 3.20 | 3.27 | 310,075 | |
| 02/19/2025 | 3.30 | 3.51 | 3.24 | 3.31 | 763,451 | |
| 02/18/2025 | 3.35 | 3.52 | 3.28 | 3.28 | 429,305 | |
| 02/14/2025 | 3.30 | 3.46 | 3.30 | 3.34 | 329,980 | |
| 02/13/2025 | 3.30 | 3.34 | 3.20 | 3.27 | 390,105 | |
| 02/12/2025 | 3.11 | 3.29 | 3.06 | 3.23 | 451,020 | |
| 02/11/2025 | 3.31 | 3.31 | 3.12 | 3.15 | 505,678 | |
| 02/10/2025 | 3.46 | 3.55 | 3.35 | 3.37 | 394,194 | |
| 02/07/2025 | 3.56 | 3.68 | 3.42 | 3.46 | 453,803 | |
| 02/06/2025 | 3.84 | 3.89 | 3.59 | 3.59 | 460,259 | |
| 02/05/2025 | 3.67 | 3.86 | 3.67 | 3.82 | 473,916 | |
| 02/04/2025 | 3.58 | 3.81 | 3.55 | 3.67 | 1,530,336 | |
| 02/03/2025 | 3.72 | 3.76 | 3.54 | 3.55 | 1,170,924 | |
| 01/31/2025 | 4.03 | 4.24 | 3.82 | 3.84 | 899,305 | |
| 01/30/2025 | 3.74 | 4.10 | 3.74 | 3.97 | 805,084 | |
| 01/29/2025 | 3.61 | 3.87 | 3.56 | 3.71 | 652,319 | |
| 01/28/2025 | 3.46 | 3.56 | 3.35 | 3.48 | 411,154 | |
| 01/27/2025 | 3.54 | 3.59 | 3.36 | 3.46 | 566,996 | |
| 01/24/2025 | 3.73 | 3.78 | 3.54 | 3.58 | 1,274,304 | |
| 01/23/2025 | 3.41 | 3.63 | 3.37 | 3.63 | 267,553 | |
| 01/22/2025 | 3.41 | 3.59 | 3.38 | 3.46 | 318,352 | |
| 01/21/2025 | 3.37 | 3.50 | 3.37 | 3.43 | 323,701 | |
| 01/17/2025 | 3.32 | 3.39 | 3.21 | 3.34 | 527,356 | |
| 01/16/2025 | 3.40 | 3.47 | 3.23 | 3.25 | 354,067 | |
| 01/15/2025 | 3.40 | 3.54 | 3.29 | 3.40 | 324,084 | |
| 01/14/2025 | 3.53 | 3.53 | 3.24 | 3.29 | 391,474 | |
| 01/13/2025 | 3.60 | 3.60 | 3.41 | 3.48 | 510,975 | |
| 01/10/2025 | 3.75 | 3.75 | 3.58 | 3.66 | 587,709 | |
| 01/08/2025 | 3.94 | 3.98 | 3.77 | 3.79 | 484,074 | |
| 01/07/2025 | 3.98 | 4.11 | 3.94 | 3.96 | 420,759 | |
| 01/06/2025 | 4.20 | 4.25 | 3.96 | 3.96 | 478,693 | |
| 01/03/2025 | 4.07 | 4.27 | 4.05 | 4.18 | 671,800 | |
| 01/02/2025 | 3.95 | 4.10 | 3.86 | 4.01 | 609,537 | |
| 12/31/2024 | 3.91 | 3.99 | 3.74 | 3.87 | 596,375 | |
| 12/30/2024 | 3.89 | 3.97 | 3.75 | 3.91 | 884,894 | |
| 12/27/2024 | 3.95 | 4.03 | 3.86 | 3.96 | 822,624 | |
| 12/26/2024 | 3.80 | 4.04 | 3.65 | 4.00 | 859,275 | |
| 12/24/2024 | 3.99 | 3.99 | 3.73 | 3.78 | 445,361 | |
| 12/23/2024 | 4.03 | 4.09 | 3.82 | 3.96 | 748,077 | |
| 12/20/2024 | 3.95 | 4.17 | 3.87 | 4.01 | 1,139,974 |
About Larimar Therapeutics Stock history
Larimar Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Larimar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Larimar Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Larimar Therapeutics stock prices may prove useful in developing a viable investing in Larimar Therapeutics
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreichs ataxia, a rare, progressive, and fatal genetic disease. Larimar Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people.
Larimar Therapeutics Stock Technical Analysis
Larimar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Larimar Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Larimar Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Larimar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Larimar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | 0.7911 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Larimar Stock Analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.